Announcements Trials
Browse Landscape

Phase

Phase NA 26Phase 3 10Phase 4 4Phase 1 4Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 264Carcinoma, Non-Small-Cell Lung 219Neoplasms 218Leukemia, Myeloid, Acute 193Multiple Myeloma 178Colorectal Neoplasms 175Melanoma 165Prostatic Neoplasms 163Lymphoma 145Leukemia 142Lymphoma, Non-Hodgkin 133Glioblastoma 131Pancreatic Neoplasms 127Neoplasm Metastasis 118Lung Neoplasms 118Leukemia, Lymphocytic, Chronic, B-Cell 118Ovarian Neoplasms 112Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Recurrence 97Myelodysplastic Syndromes 93Hodgkin Disease 92Lymphoma, Large B-Cell, Diffuse 89Lymphoma, Follicular 89Lymphoma, Mantle-Cell 83Head and Neck Neoplasms 79Carcinoma, Renal Cell 79Brain Neoplasms 77Sarcoma 73Carcinoma, Hepatocellular 73Squamous Cell Carcinoma of Head and Neck 71

Interventions

telapristone acetate 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Myofibroma × Clear all
NCT01069094 2014-06-30

A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata

Repros Therapeutics Inc.

Phase 1/2 Completed
29 enrolled

Leiomyoma, Myofibroma

NCT00837161 2012-12-04

Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids

Philips Healthcare

Phase 1/2 Completed
11 enrolled 9 charts

Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡